FINOXLAB 20 MG 20 TABLETS

Indications: Treatment of chronic kidney disease (stage 1 to 4 with albuminuria) associated with type 2 diabetes in adults. Reduction of the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes.